abstract | Systemic sclerosis (SSc) is characterized by vascular alterations, activation of the immune system and tissue fibrosis. Vascular insufficiency manifests early in the disease, and although there is evidence of an active repair process, capillaries deteriorate and regress. Factors that contribute to the failure of vascular regeneration might include persistent injury, an imbalance between proangiogenic and antiangiogenic mediators, intrinsic abnormal properties of the cellular components of the vessels, and the presence of fibroblast-derived antiangiogenic factors. In addition, circulating dysfunctional endothelial progenitor cells might further exacerbate vessel deterioration. Abnormal expression of transcription factors, including Fra2 and Fli1, has been proposed to contribute to SSc vasculopathy. Fli1 regulates genes that are involved in vessel maturation and stabilization, suggesting that reduced levels of Fli1 in SSc vasculature could contribute to the development of unstable vessels that are prone to regression. Conversely, proliferating endothelial cells and pericytes, in the presence of an appropriate stimulus, might transdifferentiate into collagen-producing cells, and thus contribute to the initiation of fibrosis. Despite progress in treating the symptoms of vascular disease in SSc, the underlying mechanisms remain poorly understood. An improved knowledge of the molecular and cellular pathways that contribute to SSc vasculopathy could help in the design of effective therapies in the future.
Introduction
systemic sclerosis (ssc) is a connective tissue and auto immune disease of unknown etiology that affects various organ systems, including the lungs, heart, gastro intestinal tract and kidneys. 1 the three major fea tures of ssc are systemic vascular dysfunction, the pre sence of mono nuclear cell infiltrates and connective tissue fibrosis. 1, 2 raynaud phenomenon is present in the majority of ssc patients and could precede a definite diagnosis of ssc by years or even decades. 3 on the basis of diagnostic cri teria proposed by leroy and medsger, 4 raynaud phe nomenon can be classified either as primary (idiopathic), in which the defect is primarily functional with no under lying secon dary disorder, or secondary to other systemic dis eases. in patients with ssc, raynaud phenomenon is associated with structural abnormalities of the micro vasculature and activation of the immune system. a large, prospective study of patients with raynaud phenomenon concluded that progressive microvascular damage and the presence of an sscspecific autoantibody pattern strongly predict development of definite ssc. 5 the event that initiates vascular injury in patients with ssc is presently unknown. Current hypotheses include the presence of infectious agents, autoantibodies against endothelial cells, cytotoxic t cells, nitricoxide related free radicals or granzyme. 6 the inter relationship between structural and functional vascular abnor malities is complex, and also not fully defined. various mechanisms, including dysfunction of endothelial cells, neural abnormalities and various intravascular defects, could contri bute to impaired vascular flow. 7 During disease progression, pathological changes in the vessels and excessive collagen accumulation occur in parallel, eventually leading to tissue ischemia and widespread fibrosis; however, immune infiltrates are usually only associated with the early stages of the disease. Factors that contribute to the progression of vascular disease remain poorly defined. vascular disease in scleroderma has been comprehensively reviewed elsewhere; 8 in this review, i will focus on the cellular and molecular aspects of ssc vasculopathy.
Morphological vascular changes
vascular disease in ssc predominantly affects the micro circulation, especially capillaries and arterioles. Capillaries consist of a layer of endothelial cells variably covered by pericytes and embedded in a shared basement membrane. structural changes in the vasculature of ssc patients have been documented in numerous studies. in 1925, Brown and o'leary, 9 using capillary microscopy of the nailfold of the fingers, recorded the first evidence of abnormal microvasculature, which included a striking decrease in the number of capillary loops, dilatation and distortion of remaining capillaries and occasional hemor rhage. subsequent studies performed more than 40 years ago demonstrated a decrease in the number of normal capil laries, swelling of microvascular endo thelial cells and reduplication of the capillary basement membrane. the earliest detectable changes consist of loss of membranebound storage vesicles in endothelial cells, cytoskeletal rearrangement, and deposition of amor phous material within the endothelial basement mem brane.
12,13 additional changes include cyto plasmic vacuolization and increased capillary permeability, resulting in edema. the results of a 20year prospective study of patients with raynaud phenomenon leading to ssc have demonstrated that microvascular damage is sequential: capillary enlargement is followed by capil lary loss and then by capillary telangiectasias. 5 Further disease progression is characterized by morphological changes in the remaining vessels occurring in parallel with tissue fibrosis. Besides the skin, vascular changes are present in the lungs, kidneys and other organs. ssc patients with pulmonary hypertension develop vascu lar lesions in smallsized and mediumsized vessels of the lung. these lesions are characterized by concen tric intimal proliferation, marked luminal obstruction and a frequent presence of infiltrating immune cells; relatively few plexiform lesions, which may result from hyper proliferation of endothelial cells, occur.
14-16 similar pathological changes, comprising intimal proliferation, medial hyperplasia and obliteration of the lumen, were reported in renal vessels. 17 However, the mechanisms underlying the pathological vascular changes in ssc remain unclear.
Defective angiogenesis the remarkable regression of the capillaries and small vessels in patients with ssc strongly suggests a defect in the process of angiogenesis; however, specific mecha nisms contributing to vessel dysfunction and subsequent deterioration have not been elucidated. angiogenesis is defined as the process by which new vessels are formed from preexisting ones. under physiological conditions, this highly regulated process requires coordination of several independent steps. 18, 19 an initial invasive phase involves detachment of pericytes (also called peri endothelial cells or mural cells) from the endothelium, degrada tion and remodeling of the basement membrane and surrounding connective tissue, and subsequent migration and proliferation of endothelial cells. the maturation phase of angiogenesis is characterized by lumenization of the sprout and deposition of new base ment membrane components, including collagen type iv and laminin. stabilization of the newly formed vessels is facilitated by the recruitment of pericytes ( Figure 1 ).
evidence of angiogenesis several studies have examined endothelial cell pro liferation in skin explants using autoradiography with 3 Hthymidine in an effort to assess angiogenesis in ssc patients; they all found considerably increased labeling in endothelial cells from the explants of ssc patients compared with those individuals without the dis ease, with especially high uptake in telangiectasias. [20] [21] [22] these observations are supported by studies in which skin explants from ssc patients were transplanted into severe combined immunodeficient (sCiD) mice or chick embryo chorioallantoic membrane, the results of which showed appreciably higher neovascularization of the ssc explants compared to skin from control indivi duals. 23, 24 evidence of endothelial cell growth has also been noted in lung tissues from ssc patients. 14,25 although con centric nonproliferative lesions predominate in ssc patients with pulmonary arterial hypertension (PaH), it has been suggested that these lesions represent a more 'mature' form of the highly proliferative plexiform lesions that are also occasionally seen in ssc lungs. 14, 16 in another study, 25 hypervascularity and irregularly sized micro vessels were observed in the early stages of pul monary fibrosis, with subsequent vessel regression and development of fibrosis.
existing studies, therefore, point to the presence of intrinsic proangiogenic factors residing in the ssc vascu lature or the adjacent tissues. the inability to regenerate injured vessels might result from the failure of subse quent stages of angiogenesis, such as lumen formation or vessel maturation or stabilization, or a combination of these processes. alternatively, persistent injury or the presence of circulating antiangiogenic factors might interfere with this process.
Imbalance of angiogenic factors one of the striking features associated with ssc vascular disease is the presence of high circulating levels of the key angiogenic mediator vascular endothelial growth factor (veGF), even at a very early disease stage (pre scleroderma). 26 the protein levels of other pro angiogenic factors, including plateletderived growth factor (PDGF), placental growth factor (PiGF) and fibroblast growth factor 2 (FGF2) are also considerably elevated in the plasma of ssc patients. 27 Furthermore, the expression of veGF and its receptors veGFr1 and veGFr2 is increased in the skin of ssc patients in vivo.
28-30 elevated levels of veGF have been found in the epidermis and in fibroblasts, endothelial cells and immune cells from the skin of ssc patients. interestingly, the enhanced expres sion of veGF does not seem to be driven by hypoxia, as indicated by the reduced levels of hypoxiainducible factor 1 (HiF1) in skin biopsies from ssc patients. 29 However, the occurrence of localized hypoxia has been noted in some groups of patients-for example, those with limited cutaneous ssc with calcinosis and in some patients with diffuse cutaneous ssc-suggesting that revIews hypoxia could be a contributing factor to increased expression of veGF in some patients. 28 although ele vated levels of veGF are consistent with active angio genesis, an uncontrolled, prolonged presence of veGF might contribute to a disorganized vascular network and eventually lead to vessel degeneration. 31 evidence also exists for the enhanced presence of cir culating antiangiogenic factors, including angiostatin, CXC chemokine ligand 4 (CXCl4, also known as plate let factor 4), thrombospondin and interleukin (il)4.
32,33
However, these factors are present only in some subsets of patients, and although they might contribute to overall vessel dysfunction, it is unlikely that they represent a primary mechanism responsible for ssc vasculopathy. Furthermore, in addition to veGF, elevated levels of other proangiogenic mediators, including endothelin 1, adhesion molecules, and some chemokines were found in the circulation of some ssc patients, 32 which is consis tent with active neoangiogenesis. whether dysregulated levels of circulating angiogenic factors or angiostatic factors (or both) are a cause or a consequence of an ongoing vascular disease is presently unknown.
Endothelial progenitor cells
although a number of studies have implicated endo thelial progenitor cells (ePCs) in the process of postnatal vasculogenesis, the role of these cells in the formation of new blood vessels is still controversial. Furthermore, owing to the scarcity of specific markers and the reliance on cell culture methods for their isolation, defining ePCs is still a matter of scientific debate. 34, 35 a variety of cells with endothelial cell characteristics have been identified that could contribute in different capacities to vessel repair and regeneration, but the concept that circulating cells can form new vessels is not supported by current evidence. 36 interestingly, results from a 2009 study have suggested that mechanical tension can give rise to new endothelium during wound healing through the recruit ment of preexisting vessels into granulation tissue. 37 thus, although it is well documented that circulating cells are mobilized and recruited into damaged or ische mic tissues, their contribution to vascular repair might be indirect, through the production of proangiogenic cytokines and chemokines. Circulating levels of ePCs in ssc patients have been reported to be either increased or decreased; this discrepancy might reflect different stages of the disease 38 or different methodo logies used to isolate these cells. apoptosis of ePCs caused by a circu lating factor present in the serum has been proposed to account for their reduced numbers in patients with ssc. 39 additionally, ePCs obtained from the bone marrow of ssc patients show a reduced angiogenic potential. 40 Given the existing uncertainty regarding the role of ePCs in neovascularization, it is currently difficult to assess the specific contributions of defects in these cells to ssc vasculopathy. interestingly, however, a pilot study has suggested that statins could be effective in improv ing raynaud phenomenon by increasing the number of circulating ePCs, 41 thus implicating ePCs in restoring endothelial dysfunction in ssc (Figure 2 ).
SSc vessels: intrinsic abnormalities
in addition to circulating factors, intrinsic proper ties of the cellular components of the capillaries and arteri oles have been proposed to contribute to vascu lar dys function in ssc patients. 42 Previous studies have identified proteins that are expressed at abnormal levels in endothelial cells and pericytes from ssc patients, [42] [43] [44] as well as altered patterns of gene expression in cultured endothelial cells derived from ssc patients, 45 suggesting a potential direct contribution of these cellular alterations to the disease process.
endothelial cells
Fleming et al. 42 have reported a highly unusual feature of dermal vessels from ssc patients in vivo. the vascula ture in the ssc dermis is characterized by the absence of vascular endothelial (ve)cadherin, 42 a main con stituent of adherens junctions that has a key role in regulating endothelial barrier function. 46 Furthermore, dermal endothelial cells from ssc patients showed evidence of activated interferon (iFn)α signaling, 42 possibly reflect ing the presence of endoplasmic reticulum stress and the unfolded protein response in these cells. 47, 48 although iFnα has been shown to have antiangiogenic and proapoptotic effects on endothelial cells, Fleming et al. revIews failed to detect apoptotic endothelial cells in their study, contrary to a previous report by sgonc et al. 49 studies performed in endothelial cells cultured from the dermis of ssc patients have revealed additional abnor mal characteristics. a comparison of global gene expres sion in endothelial cells from ssc and control skin demon strated the differential expression of 3.2% of total gene transcripts. 45 although the ssc endothelial cells exhi bited a proangiogenic gene expression pattern, which is consistent with the studies discussed above, these cells showed reduced angiogenic properties in in vitro func tional studies. this reduced capability was linked to the cleavage (by matrix metalloproteinase 12 [mmP12]) of urokinasetype plasminogen activator receptor (uPar) and a resulting loss of uPar connection with β 2 integrin, which is required for endothelialcellmediated angio genesis. 50 Furthermore, ssc fibroblasts were shown to inhibit angiogenesis in vitro through the mmP12-uPar dependent mechanism, 51 further supporting the potential pathological role of mmP12 in ssc vasculopathy.
Pericytes
Pericytes are key mediators of vascular maturation and stabilization during angiogenesis. 52 Dysregulation of pericyte function is associated with several pathological processes, including tumorigenesis and diabetic nephro pathy. 53 abnormal characteristics of micro vascular pericytes have also been reported in patients with early ssc and autoimmune raynaud phenomenon. 44, 54 in ssc lesions, pericytes are characterized by the expression of PDGF receptor β (PDGFrβ) and high molecular weight melanomaassociated antigen (Hmwmaa), which are markers of pericyte activation. another marker of angiogenic pericytes, regulator of G protein signaling 5 (rGs5), is also highly expressed in ssc vasculature. 42 although the specific functions of rGs5 are not well understood, current studies indicate that it is a negative regulator of vessel maturation. 55 studies in mice have shown that pericytes that lack rGs5 predominantly express markers associated with mature pericytes, such as αsmooth muscle actin (αsma) and the nG2 proteo glycan, whereas rGs5positive pericytes show features of immature pericytes, characterized by the expression of PDGFrβ and low levels of αsma. 56 Consistent with these observations, pericyte hyperplasia in the periph eral zones of active disease that correlated with increased capillary density has been observed in cases of diffuse and limited ssc. 57 in addition, expression of αsma has been shown to be reduced in the vasculature of ssc patients, especially in the capillaries and venules, further supporting the concept of the presence of immature or activated pericytes in ssc lesions, which is consistent with angiogenesis. 43 together, these studies suggest that endothelial cells and pericytes both undergo changes during early stages of ssc.
Basement membrane vascular basement membrane is an important struc tural and functional component of blood vessels, and is composed of type iv collagen, laminin, heparan sulfate proteoglycans, nidogen, perlecan and other minor pro teins. vascular basement membrane components have an important role in angiogenesis, especially during initia tion and resolution stages. 58 as discussed above, struc tural changes in the basement membrane are observed early in ssc. Furthermore, analyses of the components of the vascular basement membrane in the skin of patients with ssc suggest possible alterations in the distribution of type iv collagen, but not fibronectin or laminin. 59 in comparison to vessels from the skin of healthy indivi duals, the levels of type iv collagen are decreased in ssc vascular basement membrane. 43, 59 Presently, however, alterations in the basement membrane in the micro vasculature of ssc patients remain poorly characterized (Figure 3) .
Dysregulation of transcription factors
transcription factors have a key role in regulating cellu lar responses to extracellular signals and environmen tal stimuli as final effectors of signaling cascades. Dys regulated expression of several transcription factors has been observed in the ssc vasculature, and might offer new clues to the disease pathogenesis.
Fos related antigen 2
Fos related antigen 2 (Fra2) is a member of the multi functional activator protein 1 (aP1) family; this family includes the bZip group of transcription factors, which are characterized by a Dnabinding domain which con tains clustered basic amino acids next to a leucinezipper motif that is responsible for mediating dimerization of the transcription factors. In healthy individuals, injury to the endothelium triggers a repair process that leads to vessel regeneration. In patients with SSc, there is evidence that endothelial cells and pericytes proliferate during the early stages of the disease, suggesting an initiation of the angiogenic process in response to injury. However, the repair process fails, ultimately leading to regression of small vessels. Studies have revealed several potential mechanisms that could account for the impairment of the angiogenic process in SSc, but the specific contribution of each of these mechanisms to SSc vasculopathy requires further evaluated. Abbreviations: EPCs, endothelial progenitor cells; SSc, systemic sclerosis. revIews nonspecific interstitial pneumonia, as well as from the dermis of patients with ssc, 61, 62 suggesting that inappro priately elevated expression of Fra2 might contribute to disease pathogenesis. transgenic mice overexpressing Fra2 underwent vascular remodeling and obliteration, and developed prominent pulmonary and dermal fibro sis. 61, 62 interestingly, in both organs vascular changes preceded the development of fibrosis, suggesting a pos sible interrelationship between these two pathological processes (see below). Furthermore, enhanced apoptosis of endothelial cells was demonstrated in the skin, but not in the lung vasculature, indicating organspecific manifestations of Fra2 overexpression.
the factors leading to tissue fibrosis in mice that over express Fra2 are not well established, but might involve an increased presence of fibrogenic mediators such as osteopontin. Fra2 does not directly influence collagen synthesis, as collagen production was not increased in cultured fibroblasts ectopically expressing Fra2. Further studies of Fra2 should clarify the mechanism that under lies the vasculopathic and fibrogenic function of this transcription factor in vivo.
Friend leukemia virus integration 1
Friend leukemia virus integration 1 (Fli1) belongs to the ets family of transcription factors, members of which are characterized by the presence of the evolutionarily con served Dnabinding ets domain. 63 Fli1 has an essential role in the regulation of genes encoding components of the extracellular matrix, including type i collagen [64] [65] [66] [67] and the multifunctional matricellular factor connective tissue growth factor (CtGF, also known as CCn2). 68 importantly, Fli1 potently inhibits collagen biosynthesis in dermal fibroblasts and its aberrant expression might have a role in the pathogenesis of cutaneous fibrosis in ssc. 64, 68 Fli1 is expressed in the skin microvasculature of healthy individuals; however, its presence is greatly reduced in endothelial and periendothelial cells from ssc skin. 67 mice with a conditional knockout of Fli1 in endothelial cells show abnormal skin vasculature, with greatly compromised vessel integrity and markedly increased vessel permeability. 43 Further studies have demonstrated that Fli1 directly regulates a number of genes that are important in the maintenance of vascular homeostasis. specifically, Fli1 deficiency in endothelial cells resulted in a consider able decrease in the expression (at the messenger rna and protein levels) of molecules involved in regulating endothelial cell-cell interactions, including vecadherin and platelet endothelial cell adhesion molecule 1 (PeCam1), and endothelialcell-pericyte interactions, including PDGFB, sphingosine1phosphate receptor 1 and the tie2 receptor. Furthermore, Fli1 deficiency led to a marked decrease in the protein levels of type iv collagen and an increase in mmP9 mrna and protein expression, suggesting that Fli1 might also contribute to alterations in the composition of the basement mem brane. 43 thus, reduced expression of Fli1 in endo thelial cells is consistent with the initial invasive stage of angio genesis, and the failure to reexpress Fli1 during the subsequent stages of angiogenesis could prevent proper vessel maturation and stabilization. notably, vascular changes resulting from Fli1 deficiency overlap to a great extent with the abnormalities observed in the vascula ture of ssc patients (table 1), suggesting that persistently reduced levels of Fli1 in endothelial cells in ssc patients could be important in disease pathogenesis.
Peroxisome proliferator-activated receptor γ Peroxisome proliferatoractivated receptor γ (PParγ), a member of the nuclear hormone receptor superfamily, is a ligandinducible transcription factor and an important regulator of glucose and lipid homeostasis. 69 the expres sion of PParγ is reportedly reduced in ssc fibroblasts. 70 treatment with the PParγ agonist rosiglitazone allevi ated profibrotic features of cultured fibroblasts from ssc revIews patients and effectively prevented bleomycininduced fibrosis in an animal model. 70, 71 PParγ expression is also reduced in the pulmonary vasculature of patients with idiopathic PaH. 72 the critical role of PParγ in maintaining pulmonary vascular homeostasis was demon strated in mouse models in which PParγ was conditionally knocked out in smooth muscle cells (smCs) or in endothelial cells. 73, 74 spontaneous pulmo nary hypertension developed in both models, but the symptoms were more pronounced in mice with targeted deletion of PParγ in smooth muscle cells.
although the function of PParγ in the pulmonary vasculature is not yet fully characterized, it has a well established role downstream of bone morpho genetic protein 2 (BmP2) in mediating anti proliferative and proapoptotic effects in arterial smCs. 74 it has also been shown that the antiproliferative effects of PParγ are in part mediated through upregulation of apolipo protein e (apoe) and adiponectin (aPn), both of which were shown to inhibit PDGFBBinduced prolifera tion of cultured smCs. 75 the pathogenic role of adipo nectin deficiency in PaH is further supported by a study that showed development of spontaneous PaH in aPn -/-mice. 76 gata-binding protein 6 the transcription factors Gata1 to Gata6 belong to a family of six related zincfinger proteins. Gata6 has an important role in lung development and morpho genesis and has been linked to lung fibrosis as a mediator of myofibroblast differentiation induced by transforming growth factor β (tGFβ). 77 Previous studies have shown that Gata6 has a critical role in the response of vascu lar smCs to injury. reduced levels of Gata6 promoted the proliferation and dedifferentiation of smCs, whereas reexpression of Gata6 in ballooninjured carotid arteries prevented the formation of vessel lesions associ ated with vascular smC phenotypic modulation. 78, 79 markedly reduced levels of Gata6 have been reported in occluded and non occluded pulmonary vessels in patients with idiopathic PaH and sscassociated PaH. 80 Further studies using cultured human endothelial cells demonstrated that the absence of Gata6 leads to the abnormal expression of a number of genes involved in vascular homeostasis; endothelial nitric oxide synthase, vecadherin and the tGFβ pseudoreceptor BmP and activin membranebound inhibitor (BamBi) are down regulated, whereas the metalloproteinases mmP1 and mmP10 are upregulated. 80 thus, loss of endothelial Gata6 might contribute to enhanced vasoconstriction and increased permeability of pulmonary vessels.
Linking vasculopathy and fibrosis
one of the key unresolved questions in ssc patho genesis is the relationship between vasculopathy and fibrosis. Pre vious studies using animal models of organ fibrosis strongly suggested that activated fibroblasts in fibrotic tissues could originate from several sources, including resident fibroblasts, circulating fibroblast pre cursors (fibrocytes), epithelial cells, endothelial cells and peri cytes. whereas epithelial-mesenchymal transition has been extensively studied in various experimental models, endothelial-mesenchymal transition has only been recog nized in the last 5 years as an important source of fibroblasts in cancer, as well as in cardiac and kidney fibrosis. 81, 82 although endothelial-mesenchymal transition has yet to be demonstrated in an animal model of ssc, analysis of ssc lesional fibroblasts suggests that a subset of activated fibroblasts might have origi nated from endothelial cells. the characteristic features of endo thelial cells, such as the presence of endoglin and constitutive activation of alK1-smad1 signaling, charac terize these ssc fibroblasts. 83, 84 as the number of capillaries in ssc decreases despite the existence of actively pro liferating endothelial cells and pericytes, it is tempting to speculate that these cells migrate into the surrounding tissues and acquire the ability to produce In the presence of TGF-β or other immune mediators (such as cytokines and chemokines), or both, endothelial cells could acquire a migratory phenotype through endothelial-mesenchymal transition and enter the surrounding tissue, where they further differentiate into collagen-producing cells. Likewise, pericytes could transdifferentiate into fibroblasts or myofibroblasts and produce collagen. In SSc, intrinsic abnormal properties of endothelial cells and pericytes might render vascular cells particularly susceptible to undergoing these transitions. Activated resident fibroblasts and fibrocytes that enter the injured tissue from the circulation are likely to represent additional source of collagen producing cells that contribute to fibrosis in SSc lesion. Abbreviations: EPCs, endothelial progenitor cells; VEGF, vascular endothelial growth factor; MMP12, matrix metalloproteinase 12; SSc, systemic sclerosis; TGF-β, transforming growth factor β. revIews collagen and other extracellular matrix proteins. 85, 86 Consistent with this notion, collagenproducing cells are found around the vessels in the early inflammatory stage of ssc. 87 such activated fibroblasts might, in turn, nega tively affect neoangiogenesis, for example, by secreting mmP12 (Figure 4) . 51 Conclusions although fibrosis is the most prominent feature of ssc, knowledge of the underlying vascular disease might be pivotal not only to the understanding of how fibrosis develops, but also in providing new insights into treat ment. the vascular repair process in ssc is abnormal and does not lead to vessel regeneration; instead, vascular cells might give rise to collagenproducing fibroblasts and contribute to the initiation of the fibrotic process. the main vascular defect has been proposed to reside within endothelial cells, which display many abnormal characteristics. Furthermore, abnormally low expres sion levels of Fli1 in the vasculature of ssc patients, possibly owing to epigenetic factors, 88 could contribute to microvessel instability and degeneration. Despite progress in the delineation of factors contributing to ssc vasculopathy and new advances in the treatment of vas cular disease in ssc, the mechanism underlying vascular disease and the relationship between vasculopathy and fibrosis remain to be elucidated. a great need exists for new animal models of ssc that would combine vascular and fibrotic aspects of the disease. an improved under standing of the relation ship between these processes could help in designing moreeffective therapies to treat this disease.
Review criteria
A search of MEDLINE and PubMed for original articles focusing on SSc vascular disease published between 1925 and 2010 was performed. The search terms used were "systemic sclerosis", "endothelial", "vascular" and "angiogenesis". All papers identified were Englishlanguage full text papers. The reference lists of identified articles were also searched for further papers.
